Hap Trading, LLC Trevena Inc Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$0.41 - $0.63 $22,550 - $34,650	-55,000 Reduced 64.03%	30,900 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.29 $23,825 - $53,922	41,800 Added 94.78%	85,900 $3,000
Q3 2021 Nov 10, 2021	SELL	$1.11 - $1.7 $11,544 - $17,680	-10,400 Reduced 19.08%	44,100 $2,000
Q2 2021 Aug 11, 2021	BUY	$1.46 - $2.25 $79,570 - $122,625	54,500 New	54,500 $6,000
Q1 2021 May 14, 2021	SELL	$1.77 - $2.93 $92,217 - $152,653	-52,100 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $110,973 - $169,846	52,100 New	52,100 $17,000
Q4 2017 Feb 09, 2018	SELL	$1.4 - $2.6 $108,220 - $200,980	-77,300 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$2.22 - $2.79 $171,606 - $215,667	77,300	77,300 $42,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.